Phosphodiesterase-5 Inhibitors Improve Clinical Outcomes, Exercise Capacity and Pulmonary Hemodynamics in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis

BACKGROUND: Several studies have compared the use of phosphodiesterase-5 (PDE5) inhibitors sildenafil or udenafil with the placebo in patients suffering from pulmonary hypertension (PH) due to left chronic heart failure (CHF), corresponding to group 2 (PH due to left heart disease) of the PH classif...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vecchis, Renato, Cesaro, Arturo, Ariano, Carmelina, Giasi, Anna, Cioppa, Carmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412522/
https://www.ncbi.nlm.nih.gov/pubmed/28496549
http://dx.doi.org/10.14740/jocmr3008w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412522/
https://www.ncbi.nlm.nih.gov/pubmed/28496549
http://dx.doi.org/10.14740/jocmr3008w

Ejemplares similares